This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Should You Retain Teladoc (TDOC) in Your Portfolio?
by Zacks Equity Research
Banking on improving revenues and strategic acquisitions, Teladoc (TDOC) holds great potential to garner benefits for investors.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Best-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Four top-ranked liquid stocks that investors can bank on for stellar returns.
Why Molina Appears an Attractive Stock for Your Portfolio
by Zacks Equity Research
Riding high on a robust revenue stream and solid streamlining measures, Molina (MOH) holds immense potential to garner benefits for investors.
Why Should You Hold Community Health in Your Portfolio?
by Zacks Equity Research
Riding high on its restructuring initiative and growth strategy, Community Health (CYH) holds immense potential to reap benefits for investors.
Anthem (ANTM) Inks Deal to Acquire Beacon Health Options
by Zacks Equity Research
Anthem (ANTM) enters into an agreement to buy Beacon Health Options for enhancing health outcomes of patients.
MGLN vs MOH: Which Health Insurance Stock is Placed Better?
by Zacks Equity Research
Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Molina (MOH) closed the most recent trading day at $155.28, moving +1.27% from the previous trading session.
Ensign Group (ENSG) on Buyout Spree to Enrich Portfolio
by Zacks Equity Research
Ensign Group (ENSG) purchases the assets of Preceptor Health Care and the real estate and operations of Golden Palms Rehabilitation and Retirement.
UnitedHealth (UNH) to Offer 20% Hike in Quarterly Dividend
by Zacks Equity Research
United Health's (UNH) shareholders of record on Jun 17, 2019 will receive this meatier dividend on Jun 25, 2019 on the back of the company's solid capital position.
Molina (MOH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: Enterprise Products, JinkoSolar, TopBuild, Molina Healthcare and Rent-A-Center
by Zacks Equity Research
Zacks.com featured highlights include: Enterprise Products, JinkoSolar, TopBuild, Molina Healthcare and Rent-A-Center
Wall Street Sees Second Best Day of the Year: 5 Winners
by Tirthankar Chakraborty
The Dow rallied more than 500 points on Jun 4, while the S&P 500 scaled above its 200-day moving average. But, most importantly, tech-heavy Nasdaq bounced back from correction territory.
Universal Health's Segmental Strength Aids, High Costs Hurt
by Zacks Equity Research
Solid segmental contributions bode well for Universal Health's (UHS) growth. However, elevated expenses are a lingering concern.
Molina Healthcare, Inc. (MOH) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Molina Healthcare, Inc. (MOH).
Take a Look at 5 Stocks With Notable Relative Price Strength
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle
by Zacks Equity Research
Zacks.com featured highlights include: ADTRAN, Cardlytics, Molina and Carlisle
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
4 Stocks to Buy Despite Year-to-Date Fall in Health Insurance
by Sapna Bagaria
Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.
Bet on These 4 Top Liquid Stocks for Solid Returns
by Zacks Equity Research
Here are four impressive liquid stocks that are poised to offer marvelous returns.
Why Is Molina (MOH) Up 1.8% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Why You Should Hold Tenet Healthcare (THC) in Your Portfolio
by Zacks Equity Research
Banking on a strong inorganic growth history and strategic divestitures, Tenet Healthcare (THC) holds immense potential to reap benefits for investors.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Hold Centene (CNC) in Your Portfolio Now?
by Zacks Equity Research
Banking on a robust revenues and strategic initiatives, Centene (CNC) has immense potential to reap benefits for investors.